Hailey Brogan, FNP | |
6681 Ridge Rd Ste 300, Parma, OH 44129-5705 | |
(440) 842-8675 | |
Not Available |
Full Name | Hailey Brogan |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 7 Years |
Location | 6681 Ridge Rd Ste 300, Parma, Ohio |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083117766 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 022178 (Ohio) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Hospitals Medical Group Inc | 4789682493 | 1466 |
Horizon Infusions, Llc | 9739301508 | 8 |
News Archive
A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society and World Council of Enterostomal Therapists. The instrument, known as the SACS Instrument, represents the first content-validated instrument to objectively assess and classify peristomal lesions by type and location in relation to an individual's stoma.
In crisis and with nowhere else to turn, thousands of patients with complex needs - serious mental and physical health problems and substance use disorders - every year flock to emergency rooms in Harris County, Texas and across the country.
Politico explores what might become of this element of the health law if Republicans win control of Congress and the White House, and attempt to unwind the law through the same budget reconciliation process that Democrats used to pass it. Other parts of the law under GOP attack include the online insurance markets where individuals and small businesses could buy coverage and the provision of federal subsidies to help some people buy coverage.
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the State Intellectual Property Office of China granted a process patent for its novel stem-cell based drug Stempeucel.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced it will showcase Dynamic Edge™ Gating Technology, recently cleared by the U.S. Food and Drug Administration, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO), now underway at the San Diego Convention Center.
› Verified 3 days ago
Entity Name | Vpa Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932386059 PECOS PAC ID: 9234041948 Enrollment ID: O20031119000596 |
News Archive
A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society and World Council of Enterostomal Therapists. The instrument, known as the SACS Instrument, represents the first content-validated instrument to objectively assess and classify peristomal lesions by type and location in relation to an individual's stoma.
In crisis and with nowhere else to turn, thousands of patients with complex needs - serious mental and physical health problems and substance use disorders - every year flock to emergency rooms in Harris County, Texas and across the country.
Politico explores what might become of this element of the health law if Republicans win control of Congress and the White House, and attempt to unwind the law through the same budget reconciliation process that Democrats used to pass it. Other parts of the law under GOP attack include the online insurance markets where individuals and small businesses could buy coverage and the provision of federal subsidies to help some people buy coverage.
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the State Intellectual Property Office of China granted a process patent for its novel stem-cell based drug Stempeucel.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced it will showcase Dynamic Edge™ Gating Technology, recently cleared by the U.S. Food and Drug Administration, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO), now underway at the San Diego Convention Center.
› Verified 3 days ago
Entity Name | University Hospitals Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society and World Council of Enterostomal Therapists. The instrument, known as the SACS Instrument, represents the first content-validated instrument to objectively assess and classify peristomal lesions by type and location in relation to an individual's stoma.
In crisis and with nowhere else to turn, thousands of patients with complex needs - serious mental and physical health problems and substance use disorders - every year flock to emergency rooms in Harris County, Texas and across the country.
Politico explores what might become of this element of the health law if Republicans win control of Congress and the White House, and attempt to unwind the law through the same budget reconciliation process that Democrats used to pass it. Other parts of the law under GOP attack include the online insurance markets where individuals and small businesses could buy coverage and the provision of federal subsidies to help some people buy coverage.
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the State Intellectual Property Office of China granted a process patent for its novel stem-cell based drug Stempeucel.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced it will showcase Dynamic Edge™ Gating Technology, recently cleared by the U.S. Food and Drug Administration, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO), now underway at the San Diego Convention Center.
› Verified 3 days ago
Entity Name | Horizon Infusions, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164671343 PECOS PAC ID: 9739301508 Enrollment ID: O20141111000714 |
News Archive
A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society and World Council of Enterostomal Therapists. The instrument, known as the SACS Instrument, represents the first content-validated instrument to objectively assess and classify peristomal lesions by type and location in relation to an individual's stoma.
In crisis and with nowhere else to turn, thousands of patients with complex needs - serious mental and physical health problems and substance use disorders - every year flock to emergency rooms in Harris County, Texas and across the country.
Politico explores what might become of this element of the health law if Republicans win control of Congress and the White House, and attempt to unwind the law through the same budget reconciliation process that Democrats used to pass it. Other parts of the law under GOP attack include the online insurance markets where individuals and small businesses could buy coverage and the provision of federal subsidies to help some people buy coverage.
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the State Intellectual Property Office of China granted a process patent for its novel stem-cell based drug Stempeucel.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced it will showcase Dynamic Edge™ Gating Technology, recently cleared by the U.S. Food and Drug Administration, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO), now underway at the San Diego Convention Center.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Hailey Brogan, FNP 500 Kirts Blvd Ste 100, Troy, MI 48084-4135 Ph: (248) 434-6169 | Hailey Brogan, FNP 6681 Ridge Rd Ste 300, Parma, OH 44129-5705 Ph: (440) 842-8675 |
News Archive
A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society and World Council of Enterostomal Therapists. The instrument, known as the SACS Instrument, represents the first content-validated instrument to objectively assess and classify peristomal lesions by type and location in relation to an individual's stoma.
In crisis and with nowhere else to turn, thousands of patients with complex needs - serious mental and physical health problems and substance use disorders - every year flock to emergency rooms in Harris County, Texas and across the country.
Politico explores what might become of this element of the health law if Republicans win control of Congress and the White House, and attempt to unwind the law through the same budget reconciliation process that Democrats used to pass it. Other parts of the law under GOP attack include the online insurance markets where individuals and small businesses could buy coverage and the provision of federal subsidies to help some people buy coverage.
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the State Intellectual Property Office of China granted a process patent for its novel stem-cell based drug Stempeucel.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced it will showcase Dynamic Edge™ Gating Technology, recently cleared by the U.S. Food and Drug Administration, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO), now underway at the San Diego Convention Center.
› Verified 3 days ago
Mrs. Margaret R Johnson, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6681 Ridge Rd Ste 3000, Parma, OH 44129 Phone: 440-842-8675 | |
Megan Soeder, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 12380 Plaza Dr, Suite 101, Parma, OH 44130 Phone: 216-898-8488 Fax: 216-362-0677 | |
Ms. Sandra Lorraine Gleisner, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 12301 Snow Rd, Parma, OH 44130 Phone: 216-621-5600 Fax: 216-479-5554 | |
Kaitlin Novak, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6707 Powers Blvd Ste 203, Parma, OH 44129 Phone: 440-845-1500 Fax: 440-845-9227 | |
Tonya M Fisher, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5500 Ridge Rd Ste 138, Parma, OH 44129 Phone: 440-340-5209 Fax: 216-243-9979 | |
Alexandria Roy, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 12380 Plaza Dr Ste 101, Parma, OH 44130 Phone: 216-898-8488 Fax: 216-362-0677 | |
Kathaleen Fox, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6681 Ridge Rd Ste 206, Parma, OH 44129 Phone: 440-845-4221 |